Matches in Wikidata for { <http://www.wikidata.org/entity/Q56982047> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q56982047 description "article scientifique publié en 2018" @default.
- Q56982047 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q56982047 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56982047 description "scientific article published on 05 October 2018" @default.
- Q56982047 description "wetenschappelijk artikel" @default.
- Q56982047 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q56982047 name "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 name "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 type Item @default.
- Q56982047 label "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 label "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 prefLabel "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 prefLabel "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 P1433 Q56982047-12ACAD45-0733-42DF-AB66-69635ABE6A15 @default.
- Q56982047 P1476 Q56982047-45FD35B1-07F5-4EB1-B57B-8F1E2B513FDA @default.
- Q56982047 P2093 Q56982047-303D3041-DCE8-45E0-A496-E6900030DA29 @default.
- Q56982047 P2093 Q56982047-4BAB1E35-F8C2-4AE4-BA02-C249C7AD9C29 @default.
- Q56982047 P2093 Q56982047-87BB6C62-B78F-43CB-8057-7481828624DA @default.
- Q56982047 P2093 Q56982047-A7EA9EFB-F2DC-4E53-962F-8C4DEA85A9BA @default.
- Q56982047 P2093 Q56982047-B15BC1A6-EDF1-43A2-B4C1-B187DB825EA0 @default.
- Q56982047 P2093 Q56982047-BCD84E06-B525-40A0-9BCB-0EF894AFD09F @default.
- Q56982047 P2093 Q56982047-C4622D50-01F9-4F59-85AA-3DC5C8D97F77 @default.
- Q56982047 P2093 Q56982047-D43C1251-F7C2-4A0F-B046-D97EBE97A84C @default.
- Q56982047 P2093 Q56982047-D9948775-B486-4333-AA2B-97236B548507 @default.
- Q56982047 P2093 Q56982047-DD8E9BE0-47EC-4414-85C6-F876566BC4F8 @default.
- Q56982047 P2093 Q56982047-E7635667-243D-4DDC-9D47-0E54AB44DFAD @default.
- Q56982047 P2093 Q56982047-FCCEB962-6491-4323-995C-1521657E9E35 @default.
- Q56982047 P304 Q56982047-9F3FBF21-4DF4-4A9A-8645-E315D92A45F0 @default.
- Q56982047 P31 Q56982047-31B0BCCA-16BF-4ABD-9336-1B65DB43C096 @default.
- Q56982047 P356 Q56982047-23BD7A41-CA84-4413-9F9F-B7BA33CE73A9 @default.
- Q56982047 P407 Q56982047-82F142DB-3A9E-465A-A309-44724E196E52 @default.
- Q56982047 P433 Q56982047-C284EA2F-43D4-44C5-804C-F9ED1414D74C @default.
- Q56982047 P478 Q56982047-B441A310-2304-4150-AFD3-ECC0DDD12882 @default.
- Q56982047 P50 Q56982047-6F05D1B0-9BAB-440B-8353-B474904E8FC0 @default.
- Q56982047 P50 Q56982047-7F980A08-1AFB-480F-A975-984100A8E0B3 @default.
- Q56982047 P50 Q56982047-81134467-A806-4181-B3B7-83E2499E3A84 @default.
- Q56982047 P50 Q56982047-DD2F7F37-7BDC-4C2C-9475-C4A4B097730B @default.
- Q56982047 P577 Q56982047-F615A701-55E6-4066-92B6-A752F16F1CE9 @default.
- Q56982047 P698 Q56982047-AC6EB58D-EC43-4230-AEF3-1A7CC540C4C1 @default.
- Q56982047 P921 Q56982047-42CCF408-2F66-40DA-B5BD-3E43BE662DBE @default.
- Q56982047 P356 1346-8138.14669 @default.
- Q56982047 P698 30289572 @default.
- Q56982047 P1433 Q18225322 @default.
- Q56982047 P1476 "Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study" @default.
- Q56982047 P2093 "Ayumi Yoshizaki" @default.
- Q56982047 P2093 "Hayakazu Sumida" @default.
- Q56982047 P2093 "Kaname Akamata" @default.
- Q56982047 P2093 "Miki Miyazaki" @default.
- Q56982047 P2093 "Ryosuke Saigusa" @default.
- Q56982047 P2093 "Shinichi Sato" @default.
- Q56982047 P2093 "Shinji Noda" @default.
- Q56982047 P2093 "Takehiro Takahashi" @default.
- Q56982047 P2093 "Tetsuo Toyama" @default.
- Q56982047 P2093 "Yohei Ichimura" @default.
- Q56982047 P2093 "Yoshihiro Kuwano" @default.
- Q56982047 P2093 "Zenshiro Tamaki" @default.
- Q56982047 P304 "1425-1433" @default.
- Q56982047 P31 Q13442814 @default.
- Q56982047 P356 "10.1111/1346-8138.14669" @default.
- Q56982047 P407 Q1860 @default.
- Q56982047 P433 "12" @default.
- Q56982047 P478 "45" @default.
- Q56982047 P50 Q87613260 @default.
- Q56982047 P50 Q87734131 @default.
- Q56982047 P50 Q88181544 @default.
- Q56982047 P50 Q92061890 @default.
- Q56982047 P577 "2018-10-05T00:00:00Z" @default.
- Q56982047 P698 "30289572" @default.
- Q56982047 P921 Q1153419 @default.